Actelion gets go-ahead to continue new drug trial
ZURICH (Reuters) - Actelion should continue a late-stage study into a new heart and lung drug, independent monitors have recommended...
Read More »ZURICH (Reuters) - Actelion should continue a late-stage study into a new heart and lung drug, independent monitors have recommended...
Read More »
By Sharon Begley and Ransdell Pierson (Reuters) - New Jersey Governor Chris Christie's choice of gastric banding has prompted questi...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Professional medical societies don't often consider costs when they're developing th...
Read More »By Pallavi Ail and Adithya Venkatesan (Reuters) - WebMD Health Corp said Chief Executive Cavan Redmond will be leaving the health in...
Read More »By Jessica Dye and Toni Clarke NEW YORK (Reuters) - A federal judge criticized the Food and Drug Administration over its refusal to ...
Read More »By Julie Steenhuysen NEW YORK (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get ...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Injuries from gasoline, lamp oil and similar chemicals have dropped considerably among sm...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Everyone knows that getting enough fiber is a secret to staying "regular," but a large ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - People with advanced cancer tend to get more aggressive care at the end of life and s...
Read More »CAPE TOWN (Reuters) - South African competition authorities will launch an investigation into the private healthcare industry, where...
Read More »